ARCHIVES

Perifosine, Sorafenib Combination Well Tolerated in Several Lymphomas

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Pretreatment with Azacitidine Achieves 28-Month Remission

August 30, 2013

AACR Receives Record Number of Abstracts

January 27, 1989

NCI Tests Early Phase Study To Hasten Drug Development

August 31, 2007

In Brief: Bogardus Heads ASTRO, Million President Elect; Woods Named Chief of NIC Contracts Review

October 27, 1989

Mammography Quality Standards Set, FDA User Fees Enacted; Oral Cancer Drugs Covered

October 16, 1992

Cancer Clinical Trials System Needs Comprehensive Review, NCI Director Says

July 11, 2003